EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Effectiveness of cardiac resynchronization therapy in cancer therapy–related cardiac dysfunction: a systematic review and meta-analysis

Andreia Magalhães, Inês Araújo iD, Martin Brabec, Miguel Nobre Menezes, Manuela Fiúza, Daniel Caldeira

Supportive Care in Cancer · 2026-11 · 34 (11)

DOI: 10.1007/s00520-026-11364-9 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Supportive Care in Cancer, online erschienen am 21.10.2026. Verfasst von Andreia Magalhães und 5 weiteren Autor:innen. Beteiligte Einrichtung: Serviço de Cardiologia, Departamento de Coração E Vasos, Centro Hospital Universitário Lisboa Norte (CHULN), ULS Santa Maria, CAML, Lisbon, Portugal. Hauptthemen laut MEDLINE: Cardiac Resynchronization Therapy, Neoplasms, Heart Diseases. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Advances in cancer treatment have increased the number of survivors, making cancer therapy–related cardiac dysfunction (CTRCD) an important concern. While cardiac resynchronization therapy (CRT) is established for heart failure with reduced ejection fraction and conduction disorders, its role in CTRCD remains unclear. We conducted a meta-analysis to assess the benefit of CRT in patients with CTRCD.

Methods

We performed a literature search of studies showing CRT outcomes in the specific group of CTRCD patients. The outcomes of interest were left ventricular ejection fraction (LVEF) and LV volume improvement. A random effects meta-analysis was done to estimate 95% confidence intervals (CI).

Results

This analysis included four studies (one prospective and three retrospective) comprising 110 patients with CTRCD, the majority (91%, n = 100) being survivors of breast cancer or lymphoma/leukemia. Baseline LVEF ranged from 18.6% ± 7.6% to 28.5% ± 3.8% (mean 24% ± 7%). After a mean follow-up of 9 ± 5 months, LVEF increased by 9.95% (95% CI 7.79–12.11) and end-systolic volume decreased by 39.17 mL (95% CI 24.99–53.35). Three studies included a control group of patients with other forms of non-ischemic cardiomyopathy who underwent CRT implantation, showing no significant difference in LVEF improvement between the two groups.

Conclusion

This meta-analysis suggests that CRT improves LVEF and LV volumes in selected patients with CTRCD, with a magnitude of reverse remodeling that appears similar to that observed in other etiologies of non-ischemic cardiomyopathy. However, the evidence is limited to small observational studies, so conclusions about clinical outcomes remain uncertain. Thus, CRT may be considered in cancer patients who meet standard criteria for CRT implantation, but the decision should be individualized and guided by multidisciplinary assessment, cancer prognosis, and competing clinical risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac Resynchronization TherapyNeoplasmsHeart DiseasesHumansStroke VolumeTreatment OutcomeVentricular Function, Left

Stichwörter der Autor:innen

Cardiac resynchronization therapyCardiotoxicityHeart failureLeft ventricular dysfunctionMeta-analysis

Autor:innen und Institutionen

  • Serviço de Cardiologia, Departamento de Coração E Vasos, Centro Hospital Universitário Lisboa Norte (CHULN), ULS Santa Maria, CAML, Lisbon, Portugal.
  • Centro Cardiovascular da Universidade de Lisboa (CCUL@RISE), Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
  • Serviço de Cardiologia, Departamento de Coração E Vasos, Centro Hospital Universitário Lisboa Norte (CHULN), ULS Santa Maria, CAML, Lisbon, Portugal. inesaraujo96@gmail.com.
  • Centro Cardiovascular da Universidade de Lisboa (CCUL@RISE), Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. inesaraujo96@gmail.com.
  • Faculty of Medicine, Pilsen - Charles University, Pilsen, Czech Republic.
  • Centro de Estudos de Medicina Baseada Na Evidência (CEMBE), Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.

ORCID-Profile: Inês Araújo

Zitieren

APA

Magalhães, A., Araújo, I., Brabec, M., Menezes, M. N., Fiúza, M., & Caldeira, D. (2026). Effectiveness of cardiac resynchronization therapy in cancer therapy–related cardiac dysfunction: a systematic review and meta-analysis. Supportive Care in Cancer, 34(11). https://doi.org/10.1007/s00520-026-11364-9

Vancouver

Magalhães A, Araújo I, Brabec M, Menezes MN, Fiúza M, Caldeira D. Effectiveness of cardiac resynchronization therapy in cancer therapy–related cardiac dysfunction: a systematic review and meta-analysis. Supportive Care in Cancer. 2026;34(11). doi:10.1007/s00520-026-11364-9

BibTeX
@article{Magalhes2026,
  author = {Magalhães, Andreia and Araújo, Inês and Brabec, Martin and Menezes, Miguel Nobre and Fiúza, Manuela and Caldeira, Daniel},
  title = {Effectiveness of cardiac resynchronization therapy in cancer therapy–related cardiac dysfunction: a systematic review and meta-analysis},
  journal = {Supportive Care in Cancer},
  year = {2026},
  volume = {34},
  number = {11},
  doi = {10.1007/s00520-026-11364-9}
}
Kostenlos starten →